Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Healthstream (HSTM) over the last 17 years, with Q3 2025 value amounting to $10.6 million.

  • Healthstream's Free Cash Flow fell 1541.89% to $10.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.7 million, marking a year-over-year decrease of 355.81%. This contributed to the annual value of $30.9 million for FY2024, which is 1898.39% down from last year.
  • Latest data reveals that Healthstream reported Free Cash Flow of $10.6 million as of Q3 2025, which was down 1541.89% from -$1.7 million recorded in Q2 2025.
  • Healthstream's 5-year Free Cash Flow high stood at $19.3 million for Q1 2025, and its period low was -$1.7 million during Q2 2025.
  • Moreover, its 5-year median value for Free Cash Flow was $7.6 million (2023), whereas its average is $7.7 million.
  • In the last 5 years, Healthstream's Free Cash Flow surged by 57434.94% in 2022 and then plummeted by 195731.71% in 2025.
  • Over the past 5 years, Healthstream's Free Cash Flow (Quarter) stood at $597000.0 in 2021, then surged by 262.81% to $2.2 million in 2022, then surged by 248.94% to $7.6 million in 2023, then plummeted by 40.12% to $4.5 million in 2024, then skyrocketed by 134.64% to $10.6 million in 2025.
  • Its Free Cash Flow stands at $10.6 million for Q3 2025, versus -$1.7 million for Q2 2025 and $19.3 million for Q1 2025.